Wegovy Pill Cost UK: Private Prices, Doses and What to Expect

Wegovy pill cost in the UK is a key consideration for anyone exploring this newly authorised oral semaglutide treatment for weight management. Approved by the MHRA in June 2026, the Wegovy tablet is available only on private prescription, with prices varying by dose strength, provider and any promotional conditions. Starting costs at lower strengths typically range from around £70 to £100 per month, rising to approximately £180 to £200 or more at the standard 25 mg maintenance dose. This guide explains what drives those price differences, how costs can accumulate over a full course of treatment, and how to compare UK providers safely and accurately.

How Much Does the Wegovy Pill Cost in the UK?

Wegovy pill prices in the UK typically start at around £70–£100 per month at lower strengths, rising to approximately £180–£200 or more per month at the 25 mg maintenance dose on private prescription.

The Wegovy pill cost in the UK varies depending on the provider, tablet strength, treatment plan and whether any introductory offer or subscription discount applies. There is no single fixed private price charged by every pharmacy.

As a general guide, privately prescribed Wegovy tablets may start from around £70 to £100 for approximately one month of treatment at the lower strengths. At the time of writing, some of the lowest advertised prices are linked to introductory offers, subscriptions or other conditions, while standard starting prices at many private providers sit closer to £90 to £100 per month.

Prices can increase as the prescribed dose rises. Across the current UK private market, higher-strength Wegovy pill treatment may cost roughly £180 to £200 per month, although individual providers may charge less or more. Availability and pricing can also change quickly, particularly because oral Wegovy is a newly launched treatment in the UK.

A useful broad estimate is therefore:

• Lower starting strengths: approximately £70–£120 per month

• Intermediate strengths: approximately £100–£140 per month

• Higher or maintenance-strength treatment: approximately £180–£200 or more per month

These figures are market ranges rather than guaranteed prices. The exact amount a patient pays depends on the provider and the dose prescribed after clinical assessment. A headline price such as "from £69" or "from £79" may refer only to the first month, the lowest strength, a new-customer offer or a longer subscription commitment. It should not automatically be interpreted as the ongoing monthly cost of treatment.

Wegovy tablets contain semaglutide and were authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) for weight management in the UK in June 2026. They are prescription-only medicines, so patients need an appropriate clinical assessment before treatment can be prescribed. Paying for a private service does not guarantee that Wegovy will be supplied if a prescriber decides it is not clinically suitable.

The standard oral dosing schedule also helps explain why one monthly price can be misleading. UK prescribing information uses four tablet strengths:

• 1.5 mg once daily as the starting dose

• 4 mg once daily as the next dose level

• 9 mg once daily as the next dose level

• 25 mg once daily as the standard maintenance dose

There is a minimum of one month at each dose level before moving to the next stage.^[2] If needed, treatment can remain at the previous dose level. This means a patient's cost may change over time rather than remaining at the same introductory price.

When comparing the cost of the Wegovy pill, it is therefore better to ask what the treatment is likely to cost at each stage rather than focusing only on the cheapest advertised starting price.

Why the Price of the Wegovy Pill Changes by Dose and Provider

Price varies because higher dose strengths cost more, and providers use different pricing models — including subscriptions, introductory offers, and bundled services — meaning the same medicine can carry significantly different advertised costs.

The price of the Wegovy pill in the UK can differ significantly between providers. Two patients prescribed the same medicine may see different advertised prices depending on where treatment is obtained and what is included in the service.

One of the main factors is dose strength. The Wegovy pill is not supplied at one fixed strength throughout treatment. Under the standard UK schedule, patients begin at 1.5 mg once daily and may progress through 4 mg and 9 mg before reaching the 25 mg maintenance dose. Private providers commonly set different prices for different strengths, and higher doses may cost more.

As a broad market guide, lower-dose treatment may begin at around £70 to £100 per month, while advertised prices for the highest strength can approach £180 to £200 per month or more. The gap between starting and maintenance costs means that a low "from" price should not be used to estimate the full cost of a year of treatment.

A second factor is the provider's pricing model. Private services may use:

• standard pay-as-you-go monthly pricing

• discounted first-month offers

• subscription plans

• multi-month commitments

• returning-patient prices

• promotional codes

• temporary launch offers

For example, a provider advertising treatment "from £69" may be genuinely offering a lower first-month price, but the ongoing cost could be higher. Another provider may advertise £99 with no equivalent introductory discount. Neither figure alone tells a patient which service will cost less over six or twelve months.

A third factor is what the advertised price includes. Depending on the service, the price may include some combination of:

• online clinical assessment

• prescriber review

• the prescribed medicine

• standard delivery

• follow-up clinical support

• access to a weight-management programme

• dietary or behavioural support

Other providers may charge separately for certain services or delivery options. Patients should check the actual terms rather than assuming every advertised monthly price covers exactly the same package.

Availability can also affect price comparisons. Oral Wegovy is new to the UK market, and availability of individual strengths may differ between pharmacies. A provider may advertise a future or higher strength before it is available for immediate dispatch, or temporarily restrict ordering because of stock levels. A price shown online is therefore not always the same as a confirmed, immediately available prescription supply.

Patients should also distinguish between a 30-tablet pack and a calendar month. Wegovy tablets are taken once daily, and private providers commonly discuss a pack as approximately one month of treatment.^[2] However, 30 days and a calendar month are not always identical, which becomes relevant when calculating a full year's expenditure.

The safest way to compare providers is to look beyond the headline starting price and check:

• the price of the dose you are actually likely to be prescribed

• whether the price changes after the first order

• whether a subscription is required

• whether delivery is included

• whether consultation or review fees apply

• the cancellation terms

• whether clinical support is included

Most importantly, patients should only use a legitimate UK service supplying prescription medicine after an appropriate clinical assessment. An unusually cheap offer from an unregulated website or social-media seller should not be treated as a normal price saving.

How Much Could Wegovy Pill Treatment Cost Over 4 Months or a Year?

The first four months of treatment could cost roughly £455–£560, with a 12-month estimate reaching approximately £1,900–£2,200 or more, depending on dose progression speed and individual provider pricing.

The total cost of Wegovy pill treatment depends on the dose schedule, how long treatment continues and the prices charged by the chosen provider. Because the standard schedule moves through several strengths, multiplying the cheapest starting price by 12 can substantially underestimate the potential annual cost.

An illustrative UK market range might look like this:

• Month 1, 1.5 mg: approximately £70–£100

• Month 2, 4 mg: approximately £90–£120

• Month 3, 9 mg: approximately £115–£140

• Month 4 onward, 25 mg: approximately £180–£200 or more per month

These are broad examples based on current advertised private-market pricing, not fixed national prices. An individual pharmacy may price the strengths differently, and promotions can move the lower end of the range.

Using those approximate figures, the first four months of treatment could cost roughly £455 to £560. This calculation assumes progression through the standard dose steps at approximately monthly intervals and then reaching 25 mg in the fourth month.

A rough six-month cost could be in the region of £800 to £1,000, depending on provider prices and whether the patient reaches and remains on the 25 mg dose.

Over 12 months, a simplified estimate based on three months of dose escalation followed by around nine months at a higher maintenance price could come to approximately £1,900 to £2,200 or more.

These calculations are deliberately approximate. They are not a treatment quote and should not be interpreted as predicting what every patient will pay. Actual costs can differ for several reasons.

First, not everyone progresses through the schedule at exactly the same speed. UK prescribing information requires a minimum of one month at each dose level and allows treatment to remain at the previous dose if needed.^[2] A prescriber may therefore keep a patient at a lower strength for longer depending on tolerability and clinical circumstances.

Second, private prices can change. A pharmacy may alter the price of one or more strengths during a year of treatment. Introductory offers may end, new discounts may appear, and market competition may change the overall range.

Third, patients may stop or pause treatment. Wegovy is not suitable for everyone, and side effects, clinical circumstances, pregnancy planning, treatment response or personal decisions can affect how long treatment continues. Patients should not continue solely because they have calculated an annual budget, nor stop or alter doses without appropriate advice because of cost concerns.

Fourth, the cheapest first-month offer may require a longer commitment. A subscription can reduce the initial advertised price while creating a different total cost over several months. Someone comparing providers should therefore calculate the total expected spend, not simply rank services by their first visible number.

A practical way to budget is to ask:

1. What is the price of my current prescribed strength?
2. What are the current prices of the next likely strengths?
3. Is the first order discounted?
4. What will I pay after the promotion ends?
5. Is there a subscription or minimum commitment?
6. Are consultations and delivery included?

This gives a more realistic view of affordability than assuming the starting price will remain unchanged throughout treatment.

Private Prescription Costs, NHS Access and How to Compare Prices Safely

Wegovy tablets are currently available only via private prescription in the UK; patients should compare ongoing maintenance prices — not just headline offers — and confirm any provider conducts a proper clinical assessment before supplying the medicine.

At the time of writing, patients seeking the Wegovy pill in the UK are generally looking at private prescription costs. Oral Wegovy has been authorised by the MHRA for weight management, but regulatory approval does not automatically mean a medicine is immediately available through routine NHS prescribing.^[1][4] Current private providers are advertising the treatment, while NHS access to the tablet formulation may change in the future as national guidance and commissioning decisions develop.

This distinction matters when discussing cost. A private Wegovy pill price is not an NHS prescription charge. Private providers set their own service and medicine prices, which is why patients may see figures ranging from introductory offers of roughly £70 per month to around £200 or more at higher strengths.

Patients who already use Wegovy injections should also avoid assuming that switching to the pill will automatically save money. The answer depends on:

• the current injection dose

• the tablet dose prescribed after clinical review

• the provider used

• introductory offers

• ongoing maintenance pricing

• whether additional fees are included

The same applies when comparing the Wegovy pill with Mounjaro or other weight-management medicines. A lower starting price does not necessarily mean lower long-term expenditure because dose escalation and maintenance costs differ between treatments. Cost should also not be the only basis for switching prescription medicines.

When comparing UK Wegovy pill prices, patients should consider the following:

1. Look at the ongoing price, not only the headline offer. A first month from £69 or £79 may be attractive, but check what the second, third and maintenance months are likely to cost.

2. Compare the same dose strength. A £99 starting dose should not be compared directly with another provider's £189 maintenance dose as though they are identical products at the same treatment stage.

3. Check for subscription conditions. Some lower prices may depend on recurring payments, minimum terms or bundled plans.

4. Check what is included. Clinical review, prescription services, delivery and follow-up support may be bundled differently.

5. Confirm that the provider is legitimate. Wegovy is a prescription-only medicine. A legitimate service should assess clinical suitability rather than allowing unrestricted purchase. Patients should be cautious of social-media sellers, websites offering Wegovy without a prescription, or prices that appear implausibly low.

6. Do not choose a dose based on price. The appropriate dose is a clinical decision. Patients should not remain at a lower dose solely because it is cheaper, increase faster to obtain a different pack, combine lower-strength tablets or change the number of tablets taken without prescriber guidance.

In summary, the Wegovy pill cost in the UK usually starts at roughly £70 to £100 per month at the lower end of the private market, with many standard starting prices around £90 to £100. Depending on the provider and dose, higher-strength treatment may reach approximately £180 to £200 per month or more. Promotional offers can reduce the initial price, while subscriptions and dose escalation can change the longer-term cost.

The most useful comparison is therefore not simply "Who advertises the cheapest Wegovy pill?" It is what will the clinically appropriate treatment cost over time, what is included in that price, and what conditions apply? Patients should check current provider pricing before ordering because advertised prices, promotions and availability can change.

Scientific References

1. First GLP-1 tablet for weight loss approved in the UK.
2. Wegovy 25 mg tablets – Summary of Product Characteristics (Reference only – not currently marketed in current form).
3. Semaglutide: a medicine to manage type 2 diabetes or treat obesity.
4. Semaglutide for managing overweight and obesity (TA875).
5. Wegovy – European Medicines Agency (EMA) EPAR.

Frequently Asked Questions